Skip to main content
TipRanks
Go Ultimate75% OFF

Samuel Colella Insider Profile

4 Followers

Samuel Colella, Director at Standard BioTools, holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 239.27K shares in Standard BioTools (Ticker: LAB), holds 59.65K shares in Genomic Health (Ticker: GHDX).

Samuel Colella's Trading History

~FLXN
Flexion Therapeutics
Nov 19, 2021―Uninformative Sell12.72M$0.00
LAB
Standard BioTools
Mar 12, 2020DirectorInformative Buy54.20K$169.16K
GHDX
Genomic Health
Oct 03, 2014―Uninformative Buy9.99K$3.78M
VCYT
Veracyte
Nov 04, 2013Director, Ten Percent OwnerUninformative Buy―$516.57K
JAZZ
Jazz Pharmaceuticals
Jan 13, 2012DirectorUninformative Sell809.34K$378.88M
ALXA
Alexza Pharmaceuticals
Jan 28, 2010―Uninformative Buy―$242.03K
SLTM
Solta Medical Inc
――――
PODD
Insulet
―Former 10% Owner―$13.63M

You May Also Like

Samuel Colella insider profile FAQ

What is the percentage of profitable transactions made by Samuel Colella?
The percentage of profitable transactions made by Samuel Colella is 94%.
What is the average return per transaction made by Samuel Colella?
The average return per transaction made by Samuel Colella is 43.60%.
What stocks does Samuel Colella hold?
Samuel Colella holds: LAB, ~FLXN, JAZZ, PODD, GHDX, ALXA, VCYT, SLTM stocks.
What was Samuel Colella’s latest transaction?
Samuel Colella’s latest transaction was an Uninformative Sell of $12.72M.
What was Samuel Colella's most profitable transaction?
Samuel Colella’s most profitable transaction was an Informative Buy of LAB stock on August 8, 2017. The return on the trade was 117.70%.
What is Samuel Colella's role in Standard BioTools?
Samuel Colella's role in Standard BioTools is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.